Professor Michael Loebinger is one of London's leading consultant respiratory physicians, based at the Royal Brompton hospital. His specialties include bronchiectasis, primary ciliary dyskinesia, cystic fibrosis, and tuberculosis, among other respiratory infections. Having obtained a first class degree in medical sciences at Cambridge University, Professor Loebinger went on to complete his clinical training at Oxford University. He completed his training and education in London, working at various hospitals across the capital, including St Thomas', Charing Cross, Hammersmith Hospitals, and the Royal Brompton.
In addition to his clinical practice, Professor Loebinger is Professor of Practice (Respiratory Medicine) at Imperial College London. A keen educator and trainer, he also supervises PhD students and is an assessor for his specialty. He is frequently invited to speak at meetings and conferences on both a national and international level.
He is actively involved in research and in 2006, he was awarded a Medical Research Council Clinical Research Training Fellowship. His research looked into the use of adult stem cells in lung disease, and gained significant media attention. His current research focuses around chronic lung infections, in particular bronchiectasis, Pseudomonas and non-tuberculosis mycobacterial infections and he has helped set up national and European research networks. He is the recipient of awards from the Royal Society of Medicine, European Respiratory Society, British Thoracic Society, British Association of Lung Research, American Thoracic Society, Medical Research Society and the British Lung Foundation. He also collaborates with industry and is global, national and site principal investigator of multicentre international clinical trials. Professor Loebinger helps to shape international practice, co-chairing the national bronchiectasis guidelines and co-writing the European bronchiectasis guidelines and national non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and is presently secretary of the European Respiratory Society respiratory infection group.